支原体肺炎,除肺部表现外,还可以引起心肌酶的变化,通过希舒美治疗组及红霉素对照组比较,提示希舒美在临床疗效、副反应少及口服给药方面明显优于红霉素静脉点滴,值得临床推广。同时提示,对心肌酶变化应密切观察,及时、经常以辅酶Q_(10)口服治疗。 Mycoplasma pneumonia, in addition to lung performance, but also can cause changes in myocardial enzymes, by Xishuomi treatment group and erythromycin control group, suggesting that the United States in the clinical efficacy of Xishuomi less side effects and oral administration was significantly better than Erythromycin intravenous drip, it is worth clinical promotion. At the same time suggest that the changes of myocardial enzymes should be closely observed, timely, often coenzyme Q_ (10) oral treatment.